Logo image of SINT

SINTX TECHNOLOGIES INC (SINT) Stock Fundamental Analysis

USA - NASDAQ:SINT - US8293927039 - Common Stock

4.14 USD
-0.21 (-4.83%)
Last: 10/10/2025, 8:57:30 PM
4.1118 USD
-0.03 (-0.68%)
After Hours: 10/10/2025, 8:57:30 PM
Fundamental Rating

3

Taking everything into account, SINT scores 3 out of 10 in our fundamental rating. SINT was compared to 191 industry peers in the Health Care Equipment & Supplies industry. While SINT seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, SINT is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

SINT had negative earnings in the past year.
In the past year SINT has reported a negative cash flow from operations.
SINT had negative earnings in each of the past 5 years.
In the past 5 years SINT always reported negative operating cash flow.
SINT Yearly Net Income VS EBIT VS OCF VS FCFSINT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M

1.2 Ratios

With a Return On Assets value of -136.42%, SINT is not doing good in the industry: 84.29% of the companies in the same industry are doing better.
SINT has a Return On Equity of -314.54%. This is in the lower half of the industry: SINT underperforms 76.44% of its industry peers.
Industry RankSector Rank
ROA -136.42%
ROE -314.54%
ROIC N/A
ROA(3y)-91.86%
ROA(5y)-74.54%
ROE(3y)-222.21%
ROE(5y)-157.01%
ROIC(3y)N/A
ROIC(5y)N/A
SINT Yearly ROA, ROE, ROICSINT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150 -200 -250

1.3 Margins

The Gross Margin of SINT (62.17%) is better than 64.40% of its industry peers.
SINT's Gross Margin has improved in the last couple of years.
SINT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 62.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y40.53%
GM growth 5Y29.13%
SINT Yearly Profit, Operating, Gross MarginsSINT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K -20K

More info and screens

6

2. Health

2.1 Basic Checks

SINT does not have a ROIC to compare to the WACC, probably because it is not profitable.
SINT has more shares outstanding than it did 1 year ago.
The number of shares outstanding for SINT has been increased compared to 5 years ago.
SINT has a worse debt/assets ratio than last year.
SINT Yearly Shares OutstandingSINT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K 1M
SINT Yearly Total Debt VS Total AssetsSINT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

SINT has an Altman-Z score of -44.57. This is a bad value and indicates that SINT is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -44.57, SINT is doing worse than 92.15% of the companies in the same industry.
There is no outstanding debt for SINT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -44.57
ROIC/WACCN/A
WACC8.86%
SINT Yearly LT Debt VS Equity VS FCFSINT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

A Current Ratio of 2.57 indicates that SINT has no problem at all paying its short term obligations.
SINT's Current ratio of 2.57 is in line compared to the rest of the industry. SINT outperforms 52.36% of its industry peers.
SINT has a Quick Ratio of 2.41. This indicates that SINT is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 2.41, SINT is doing good in the industry, outperforming 60.21% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.57
Quick Ratio 2.41
SINT Yearly Current Assets VS Current LiabilitesSINT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

4

3. Growth

3.1 Past

SINT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 98.14%, which is quite impressive.
Looking at the last year, SINT shows a very negative growth in Revenue. The Revenue has decreased by -40.47% in the last year.
The Revenue has been growing by 33.18% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)98.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%74.79%
Revenue 1Y (TTM)-40.47%
Revenue growth 3Y68.26%
Revenue growth 5Y33.18%
Sales Q2Q%-82.42%

3.2 Future

Based on estimates for the next years, SINT will show a very strong growth in Earnings Per Share. The EPS will grow by 35.75% on average per year.
SINT is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -23.12% yearly.
EPS Next Y78.45%
EPS Next 2Y35.75%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-67.16%
Revenue Next 2Y-23.12%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SINT Yearly Revenue VS EstimatesSINT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M 20M
SINT Yearly EPS VS EstimatesSINT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 -50M -100M -150M -200M -250M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SINT. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SINT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SINT Price Earnings VS Forward Price EarningsSINT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SINT Per share dataSINT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4

4.3 Compensation for Growth

SINT's earnings are expected to grow with 35.75% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.75%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SINT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SINTX TECHNOLOGIES INC

NASDAQ:SINT (10/10/2025, 8:57:30 PM)

After market: 4.1118 -0.03 (-0.68%)

4.14

-0.21 (-4.83%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-14 2025-08-14/amc
Earnings (Next)11-10 2025-11-10
Inst Owners5.93%
Inst Owner Change4.61%
Ins Owners8.6%
Ins Owner Change62.75%
Market Cap11.43M
Analysts82.86
Price Target28.56 (589.86%)
Short Float %7.78%
Short Ratio0.19
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-40.22%
Min EPS beat(2)-67.51%
Max EPS beat(2)-12.93%
EPS beat(4)2
Avg EPS beat(4)8.53%
Min EPS beat(4)-67.51%
Max EPS beat(4)75.98%
EPS beat(8)5
Avg EPS beat(8)25.39%
EPS beat(12)6
Avg EPS beat(12)-27.77%
EPS beat(16)9
Avg EPS beat(16)-16.57%
Revenue beat(2)0
Avg Revenue beat(2)-56.55%
Min Revenue beat(2)-62.99%
Max Revenue beat(2)-50.1%
Revenue beat(4)1
Avg Revenue beat(4)-31.32%
Min Revenue beat(4)-62.99%
Max Revenue beat(4)11.9%
Revenue beat(8)4
Avg Revenue beat(8)-11.71%
Revenue beat(12)6
Avg Revenue beat(12)0.62%
Revenue beat(16)8
Avg Revenue beat(16)-0.62%
PT rev (1m)0%
PT rev (3m)-6.67%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-37.5%
Revenue NY rev (3m)-37.5%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.14
P/FCF N/A
P/OCF N/A
P/B 2.87
P/tB 2.88
EV/EBITDA N/A
EPS(TTM)-4.87
EYN/A
EPS(NY)-2.56
Fwd EYN/A
FCF(TTM)-2.76
FCFYN/A
OCF(TTM)-2.68
OCFYN/A
SpS0.67
BVpS1.44
TBVpS1.44
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -136.42%
ROE -314.54%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 62.17%
FCFM N/A
ROA(3y)-91.86%
ROA(5y)-74.54%
ROE(3y)-222.21%
ROE(5y)-157.01%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y40.53%
GM growth 5Y29.13%
F-Score3
Asset Turnover0.2
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 43.82%
Cap/Sales 11.82%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.57
Quick Ratio 2.41
Altman-Z -44.57
F-Score3
WACC8.86%
ROIC/WACCN/A
Cap/Depr(3y)184.27%
Cap/Depr(5y)590.89%
Cap/Sales(3y)44.69%
Cap/Sales(5y)162.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%74.79%
EPS Next Y78.45%
EPS Next 2Y35.75%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-40.47%
Revenue growth 3Y68.26%
Revenue growth 5Y33.18%
Sales Q2Q%-82.42%
Revenue Next Year-67.16%
Revenue Next 2Y-23.12%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y33.2%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year58.24%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y44.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y41.29%
OCF growth 3YN/A
OCF growth 5YN/A